Antimicrobial and toxicological activities of five medicinal plant species from Cameroon Traditional Medicine

BMC Complementary and Alternative Medicine

Volumn 11, Issue , 2011, Pages

  Assob, Jules C N ^a   Kamga, Henri L F ^a   Nsagha, Dickson S ^a   Njunda, Anna L ^a   Nde, Peter F ^a   Asongalem, Emmanuel A ^a   Njouendou, Abdel J ^a   Sandjon, Bertrand ^b   Penlap, Veronique B ^c  

^a UNIVERSITY OF BUEA   (Cameroon)

^b Laboratoire Phytorica   (Cameroon)

^c UNIVERSITY OF YAOUNDÉ I   (Cameroon)

Author keywords

Acute toxicity kidney and liver function tests; Antimicrobial; Cameroon Traditional Medicine; Phyllanthus muellerianus; Piptadeniastum africana

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CISSUS ARALIOIDES EXTRACT; GLADIOLUS GREGASIUS EXTRACT; HILERIA LATIFOLIA EXTRACT; PHYLLANTHUS MUELLERIANUS EXTRACT; PIPTADENIASTUM AFRICANA EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

AFRICAN MEDICINE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; CAMEROON; CANDIDA ALBICANS; CANDIDA KRUSEI; CISSUS ARALIOIDES; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; GLADIOLUS GREGASIUS; HILERIA LATIFOLIA; KLEBSIELLA PNEUMONIAE; MALE; MEDICINAL PLANT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYLLANTHUS MUELLERIANUS; PIPTADENIASTUM AFRICANA; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; RAT; SALMONELLA TYPHI; SHIGELLA FLEXNERI; STAPHYLOCOCCUS AUREUS; ANIMAL; BACTERIAL INFECTION; BACTERIUM; CHEMISTRY; DRUG EFFECT; FUNGUS; HUMAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MYCOSIS; TRADITIONAL MEDICINE; WISTAR RAT;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIA; BACTERIAL INFECTIONS; CAMEROON; FEMALE; FUNGI; HUMANS; MALE; MEDICINE, TRADITIONAL; MICROBIAL SENSITIVITY TESTS; MYCOSES; PLANT EXTRACTS; PLANTS, MEDICINAL; RATS; RATS, WISTAR;

EID: 80053257896     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-11-70     Document Type: Article

References (48)

1. Iwu MM, Duncan AR, Okunji CO. New antimicrobials of Plant Origin. Perspectives on new crops and new uses. 1999, 457-462. ASHS Press, Alexandria, VA, Janick J.
2. Pinner RS, Teutsch LS, Klug L, Graber J, Clarke M, Berkelman R. Trends in infectious diseases mortality in the United States. J Am Med Assoc 1996, 275:189-193.
3. Cos PM, Sindambiwe LW, Vlietinck AJ, Berghe DV. Bioassays for Antibacterial and Antifungal Activities 2006, 19-28. Biological Screening of plant constituents. Training manual, International centre for science and high technology. Trieste, Mahabir P, Gupta S, Swami H, Karan V.
4. Diallo D, Hveem B, Mahmoud MA, Betge G, Paulsen BS, Maiga A. An ethnobotanical survey of herbal drugs of Gourma district, Mali. Pharm Biol 1999, 37:80-91.
5. Kuete V. Potential of Cameroonian Plants and Derived Products against Microbial Infections: A Review. Planta Med 2010, 76:1479-1491.
6. Assob NJC, Weledji EP, Njunda AL, Bolimo F, Asongalem EA, Kamga FHL, Achidi EA, Penlap BV, Ndumbe PM. Bacteriological and mycological characterization of some pathogens of the urogenital tract in Buea subdivision (South West Region Cameroon). Health Sci & Dis 2009, 10:10-16.
7. Adjanohoun JE, Aboubabakar N, Dramane K, Ebot ME, Ekpere JA, Enow Orock EG, Focho D, Gbile ZO, Kamanyi A, Kamsu kom J, Keita A, Mbenkum T, Mbi CN, Mbiele AL, Mbome H, Mubiru NK, Nancy WL, Nkonmeneck B, Satabie B, Sofowara A, Tamze V, Wirmum VK. Contribution to ethnomedicinal and floristic studies in Cameroon. Traditional medicine and pharmacopoeia 1996, Addis Ababa. CST/OUA.
8. Bruneton J. Pharmacognosie, phytochimie des plantes médicinales 2000, Tec-Et Doc. Edition médicale. Paris, 3.
9. Harbone JB. Phytochemical methods. A guide to modern techniques of plant analyses 1976, 150. Chapman and hall, London.
10. Berghe VA, Vlietinck AJ. Screening Methods for Antibacterial and Antiviral Agents from Higher plants. Methods of plants Biochemistry 1991, 47-69. Academic Press Limited. New York.
11. Perez C, Paul M, Bazerque P. An Antibiotic assay by the agar well-diffusion method. Acta Bio Med Exp 1990, 15:113-115.
12. Collins CH, Lynes PM, Grange JM. Microbiological Methods. 1995, 175-190. Butterwort-Heinemann Ltd., Britain, 7.
13. WHO Research guidelines for evaluating the safety and efficacy of herbal medecine. 1992, 38. Manila, Phillipines, WHO.
14. Berhens B, Karber G. "Mathematics for naturalists and agriculturalists". 1983, 218-219. PWN, Warsaw.
15. Delongeas JL, Burnel D, Netter P, Grignon M, Mur JM, Royer R, Grignon G. Toxicité et pharmacocinétique de l'oxychlorure de zirconium chez la souris et chez le rat. J Pharmacol 1983, 14:437-447.
16. Shorderet M. Des concepts fondamentaux aux applications thérapeutiques 1989, 30-43. Pharmacologie. Edition Slatkine. Genève.
17. Lu FC. Données générales, Procédures d'évaluation, organes cibles et évaluation du risque. Toxicologie 1992, 3-87. Masson, Paris.
18. Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. American J Clinl Pathol 1957, 28-58.
19. Cheesbrough M. Medical Laboratory Manual for tropical countries. Vol. 2 Microbiology 1985, EIBS pub. Low price Edition.
20. Wilbur KM, Berhein F, Shapiro OW. Dosage du malondialdehyde. Arch Biophys 1949, 24:305.
21. Ellman GL. Tissue sulphurhidryl groups. Arch Biophys 1949, 82:70-77.
22. Wonnacott TH, Wonnacott RJ. Statistique: Economie-Gestion-Sciences Médecine 1995, Economia. Paris, 4.
23. Houghton P, Hawkes RP, Jane E. Naphtoquinones and an alkaloid from roots of Newbouldia laevis. Phytochem 1994, 35:1602-3.
24. Tsuchiya HMS, Miyazaki T, Fujiwara S, Tanigaki S, Ohyama M, Tanaka T, Iinuma M. Comparative study on the antibacterial activity of phytochemical flavanones against methicillin-resistant Staphylococcus aureus. J Ethnopharmacol 1996, 50:27-34.
25. Thornes RD. Clinical and biological observations associated with coumarins. Coumarins: biology, applications and mode of action 1997, 256. John Wiley & Sons, Inc., New York, N.Y., O'Kennedy R, Thornes RD.
26. Phillipson JD, O'Neill MJ. New leads to the treatment of protozoal infections based on natural product molecules. Acta Pharm Nord 1987, 1:131-144.
27. Mbouangouere RN, Tane P, Ngamga D, Djemgou P, Choudhary MI, Ngadjui BT. Piptaderol from Piptadenia africana. Afr J Trad CAM 2007, 4:294-298.
28. De Boer HJ, Kool A, Broberg A, Mziray WR, Hedberg I, Levenfors JJ. Antifungal and antibacterial activity of some herbal remedies from Tanzania. J Ethnopharmacol 2005, 96:461-469.
29. Schmelzer GH. Hilleria latifolia (Lam.) H. Walter 2007, 11. Prota. Medicinal plants/Plantes médicinales [CD-Rom]. PROTA, Wageningen, Pays Bas, Schmelzer GH, Gurib-Fakim A.
30. Buwa LV, Staden JV. Antibacterial and antifungal activity of traditional medicinal plants used against venereal diseases in South Africa. J Ethnopharmacol 2006, 103:139-142.
31. Parekh J, Jadeja S, Chanda. Efficacy of Aqueous and Methanol Extracts of some Medicinal Plants for Potential Antibacterial Activity. Turk J Biol 2005, 2:20-210.
32. Recio MC, Giner RM, Manez S, Gueho J, Julien HR, Hostettmann K. Investigations on the steroidal anti-inflammatory activity of triterpenoids from Diospyros leucome- las. Planta Med 1995, 61:9-12.
33. Supaluk P, Puttirat S, Rungrot C, Somsak R, Virapong P. New bioactive triterpenoids and antimalarial activity of Diospyros rubra lec. EXCLI J 2010, 9:1-10.
34. Vlietinck AJ, Van Hoof L, Totte J, Lasure A, Vanden Berghe D, Rwangobo PC, Mvukiyuniwami J. Screening of hundred Rwandese medicinal plants for antimicrobial and antiviral properties. J Ethnopharmacol 1995, 46:31-47.
35. Abotsi WKM, Ainooson GK, Gyasi EB. Acute and Sub-acute Toxicity Studies of the Ethanolic Extract of the Aerial Parts of Hilleria Latifolia (Lam.) H. Walt. (Phytolaccaceae) in Rodents. West Afr J Pharma 2011, 22:27-35.
36. Assob Nguedia JC, F-X E, Penlap Beng V, Lontsi D, Kuete V, Somo Moyou R. Anti-candidal property and acute toxicity of Gladiolus gregasius Baker (Iridaceae). Pharm Méd Trad Afr 2004, 13:149-159.
37. Ncube NS, Afolayan AJ, Okoh AI. Assessment techniques of antimicrobial properties of natural compounds of plant origin: current methods and future trends. Afr J Biotech 2008, 7:1797-1806.
38. Doughari JH, Sunday D. Antibacterial Activity of Phyllanthus muellerianus. Pharma Biol 2008, 46:400-405.
39. Brusotti G, Cesari I, Frassà G, Grisoli P, Dacarro C, Caccialanza G. Antimicrobial properties of stem bark extracts from Phyllanthus muellerianus (Kuntze) Excell. J Ethnopharmacol 2011, 03:042.
40. Gulati RK, Agarwal S, Agrawal SS. Hepatoprotective studies on Phyllanthus emblica Linn. and quercetin. Indian J Exp Biol 1995, 33:261-8.
41. Pornpen P, Patcharavadee S, Somlak P, Chaiyo C. The protective effects of Phyllanthus emblica Linn. extract on ethanol induced rat hepatic injury. J Ethnopharmacol 2006, 107:361-364.
42. Prakash A, Satyan KS, Wahi SP, Singh RP. Comparative hepatoprotective activity of three Phyllanthus species, P. urinaria, P. niruri and P. simplex, on carbon tetrachloride induced liver injury in the rat. Phytother Res 2006, 9:594-596.
43. Panchabhai TS, Ambarkhane SV, Joshi AS, Samant BD, Rege NN. Protective effect of Tinospora cordifolia, Phyllanthus emblica and their combination against antitubercular drugs induced hepatic damage: an experimental study. Phytotherapy research PTR (2008) Phytother Res 2008, 22:646-650.
44. Wanda HM, Colin RG, Matthew WA. The Liver, in Fundamentals of Toxicologic Pathology (Second Edition). 2010, 197-235.
45. Dweck AC, Mitchell D. Emblica officinalis [Syn: Phyllanthus emblica] or Amla: the Ayurvedic wonder. 2002, Chesham Chemicals Ltd. London.
46. Jeong HG. Inhibition of cytochrome P450 2E1 expression by oleanolic acid: hepatoprotective effects against carbon tetrachloride-induced hepatic injury. Toxicol Lett 1999, 105:215-222.
47. Liu J, Liu Y, Klaassen CD. Protective effect of oleanolic acid against chemical-induced acute necrotic liver injury in mice. Acta Pharm Sin 1995, 16:97-102.
48. Balanehru S, Nagarajan B. Protective effect of oleanolic acid and ursolic acid against lipid peroxidation. Biochem Int 1991, 24:981-990.